Hou, Li, Moi et al., find that long-term endocrine therapy does not alter overall gut microbiota composition in breast cancer patients, but recurrence is linked to reduced microbial diversity and specific bacterial signatures. These gut microbiota patterns predict poorer outcomes independent of established genetic risk scores, suggesting added value for recurrence risk stratification
- Ming-Feng Hou
- Chung-Liang Li
- Chih-Po Chiang
